on! PLUS(TM) Expands Nationwide Retail Availability
MWN-AI** Summary
Altria Group, Inc. (NYSE: MO) has announced the nationwide expansion of its on! PLUS™ nicotine pouches, developed by its subsidiary Helix Innovations LLC. This marks a significant step in Altria's commitment to transitioning smokers to smoke-free alternatives as part of its initiative, Moving Beyond Smoking®.
The on! PLUS™ products are noteworthy as the first nicotine pouches authorized through the U.S. Food and Drug Administration’s (FDA) pilot program, aimed at expediting the review of nicotine products. Altria is positioning these pouches to meet the growing consumer demand for smoke-free options. Available in three flavors—Mint, Tobacco, and Wintergreen—at nicotine strengths of 6 mg and 9 mg, the pouches also feature proprietary NICOSLIK technology and a built-in disposal compartment, promoting responsible use.
The roll-out began with e-commerce availability and select retailers in North Carolina, Florida, and Texas, with wholesale deliveries slated to start on March 16, 2026. Nationwide distribution is set to reach participating retailers by March 23, 2026.
Altria, a leading player in the U.S. tobacco industry, aligns with regulatory frameworks to foster innovations within the nicotine sector. Its diversified portfolio includes brands like Marlboro® and Skoal®, as well as holdings in e-vapor products and cannabis through investments in companies like Anheuser-Busch InBev and Cronos Group.
While Altria is optimistic about the future of its on! PLUS™ product line, the company has issued cautionary notes regarding forward-looking statements, acknowledging potential delays and other risks that could affect product availability. The company remains committed to advancing smoke-free options for adult consumers, reflecting a broader vision for responsibly navigating the evolving nicotine landscape.
MWN-AI** Analysis
Altria Group, Inc. (NYSE: MO) has recently announced the nationwide expansion of its on! PLUS™ nicotine pouches, marking a significant development in its portfolio and strategy to transition towards smoke-free alternatives. This innovative product is the first to be authorized under the FDA's pilot program for expedited review, positioning it as a potentially key player in the growing nicotine pouch market.
From a market perspective, Altria's move to expand on! PLUS is timely. The increasing demand for smoke-free nicotine products continues to reshape consumer preferences. Investors should take note of this trend; companies like Altria that adapt to market shifts may enhance their long-term growth prospects. With three available flavors and two nicotine strengths, on! PLUS is crafted with proprietary NICOSLIK technology, boosting its appeal to health-conscious consumers seeking alternatives to traditional tobacco products.
As the product is set to reach retailers nationwide beginning March 23, 2026, it is crucial to monitor early sales data closely. A successful launch could significantly impact Altria's revenue stream and bolster its image as a responsible player in the tobacco industry, aligned with their Vision of "Moving Beyond Smoking."
However, investors should remain cognizant of the regulatory landscape and potential competition from other nicotine alternatives entering the market. Additionally, any delays in product deliveries or unforeseen regulatory hurdles could impact projected outcomes.
In summary, Altria’s strategic expansion of on! PLUS nicotine pouches presents a promising opportunity for growth in the evolving nicotine landscape. Investors should assess market reception of the product and consider the broader implications of regulatory developments in the tobacco sector when making investment decisions.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Altria Group, Inc. (Altria) (NYSE: MO) today announced the national retail expansion of on! PLUS ™ nicotine pouches, a next-generation oral nicotine pouch product manufactured by Helix Innovations LLC (Helix), an Altria operating company.
“The national expansion of on! PLUS is an exciting milestone for Helix and a meaningful step forward in Altria’s Vision of Moving Beyond Smoking ® . As adult consumers continue to seek smoke?free alternatives, on! PLUS reflects our focus on quality, innovation, and responsibly meeting demand within science?based regulatory frameworks,” said Nick MacPhee, Managing Director, Helix.
on! PLUS is the first product authorized through the U.S. Food and Drug Administration’s pilot program designed to expedite the review of nicotine pouch product premarket tobacco product applications. on! PLUS, available in three flavors and two nicotine strengths, features our proprietary NICOSLIK technology and a built-in compartment for responsible disposal.
Building on its availability through e?commerce and at participating retailers in North Carolina, Florida, and Texas, on! PLUS began wholesale deliveries on March 16, 2026. It is expected to reach participating retailers nationwide beginning March 23, 2026.
FDA-authorized on! PLUS products
The FDA authorized the marketing of the following on! PLUS nicotine pouch products:
- on! PLUS Mint, 6 mg
- on! PLUS Mint, 9 mg
- on! PLUS Tobacco, 6 mg
- on! PLUS Tobacco, 9 mg
- on! PLUS Wintergreen, 6 mg
- on! PLUS Wintergreen, 9 mg
Altria’s Profile
We have a leading portfolio of nicotine products for U.S. nicotine consumers age 21+. We are Moving Beyond Smoking ® by responsibly transitioning adult smokers to a smoke-free future, competing vigorously for existing smoke-free adult nicotine consumers (ANC) and exploring new growth opportunities — beyond the U.S. and beyond nicotine (Vision). To achieve our Vision, we will pursue initiatives designed to promote the long-term welfare of our company, our stakeholders, society at large and the environment.
Our wholly owned subsidiaries include leading manufacturers of both combustible and smoke-free products. In combustibles, we own Philip Morris USA Inc. (PM USA), the most profitable U.S. cigarette manufacturer, and John Middleton Co. (Middleton), a leading U.S. cigar manufacturer. Our smoke-free portfolio includes ownership of U.S. Smokeless Tobacco Company LLC (USSTC), the leading global moist smokeless tobacco (MST) manufacturer, Helix Innovations LLC (Helix), a leading manufacturer of oral nicotine pouches, and NJOY, LLC (NJOY), an e-vapor manufacturer with products covered by marketing granted orders from the U.S. Food and Drug Administration (FDA).
Additionally, we have a majority-owned joint venture, Horizon Innovations LLC (Horizon), for the U.S. marketing and commercialization of heated tobacco stick products.
Our equity investments include Anheuser-Busch InBev SA/NV (ABI), the world’s largest brewer, and Cronos Group Inc. (Cronos), a leading Canadian cannabinoid company.
The brand portfolios of our operating companies include Marlboro ® , Black & Mild ® , Copenhagen ® , Skoal ® , on! ® and NJOY ® . Trademarks related to Altria referenced in this release are the property of Altria or our subsidiaries or are used with permission.
Forward-Looking and Cautionary Statements
This release contains certain forward-looking statements that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to the availability of our operating companies’ products at retail, and we cannot guarantee any outcomes. Factors that might cause actual results to differ materially from those contained in the forward-looking statements included in this press release include delays with respect to product deliveries, among others. Other risk factors are detailed from time to time in our publicly filed reports, including our Annual Report on Form 10-K for the year ended December 31, 2025. These forward-looking statements speak only as of the date of this press release. We assume no obligation to provide any revisions to, or update, any projections and forward-looking statements contained in this release.
Learn more about Altria at www.altria.com and follow us on X, Facebook and LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260323694075/en/
Investor Relations
Altria Client Services
(804) 484-8222
Media Relations
Altria Client Services
(804) 484-8897
www.altria.com/contact-us/media
FAQ**
How will the national retail expansion of on! PLUS nicotine pouches impact Altria Group Inc. MO's overall market share in the smoke-free product segment?
What specific strategies is Altria Group Inc. MO implementing to promote the adoption of on! PLUS among adult consumers seeking smoke-free alternatives?
Can Altria Group Inc. MO provide insights on the financial projections associated with the launch of on! PLUS, considering its FDA authorization and competitive landscape?
How does Altria Group Inc. MO plan to address potential regulatory challenges that may arise with the expansion of on! PLUS nicotine pouches in the future?
**MWN-AI FAQ is based on asking OpenAI questions about Altria Group Inc. (NYSE: MO).
NASDAQ: MO
MO Trading
-0.84% G/L:
$67.085 Last:
2,328,658 Volume:
$67.47 Open:
